2004
DOI: 10.1111/j.1365-2133.2004.06317.x
|View full text |Cite
|
Sign up to set email alerts
|

The place of botulinum toxin type A in the treatment of focal hyperhidrosis

Abstract: Botulinum toxin type A injections are an effective and well-tolerated treatment for hyperhidrosis. This paper proposes a positioning of this treatment along with current established treatments, and highlights the role of botulinum toxin type A as a valuable therapy for the treatment of hyperhidrosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
61
0
9

Year Published

2009
2009
2019
2019

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 95 publications
(70 citation statements)
references
References 48 publications
0
61
0
9
Order By: Relevance
“…In most studies presented in the literature, the authors concentrate on relative impact of different forms of treatment on gravimetrically measured sweating [3,4,[10][11][12][13][14][15][16][17][18][19]. Mostly, such measurements were performed in dermatological settings and concerned the results of botox treatment [3,4,[13][14][15][16][17]19] or iontophoresis [12].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In most studies presented in the literature, the authors concentrate on relative impact of different forms of treatment on gravimetrically measured sweating [3,4,[10][11][12][13][14][15][16][17][18][19]. Mostly, such measurements were performed in dermatological settings and concerned the results of botox treatment [3,4,[13][14][15][16][17]19] or iontophoresis [12].…”
Section: Discussionmentioning
confidence: 99%
“…Mostly, such measurements were performed in dermatological settings and concerned the results of botox treatment [3,4,[13][14][15][16][17]19] or iontophoresis [12]. In those methods of treatment, associated with low level of transient complications or side effects, even less stringent approach to qualification will not cause longterm harm to the patients.…”
Section: Discussionmentioning
confidence: 99%
“…Die Anwendung erfolgt initial meist 5-mal pro Woche und wird nach therapeutischem Ansprechen als Erhaltungsdosis auf 1-bis 2-mal wöchentliche Anwendungen reduziert [22,23]. Die Stromstärke kann individuell angepasst werden; moderne Geräte bieten darüber hinaus Schutzfunktionen gegenüber dem sog.…”
Section: Leitungswasser-iontophoreseunclassified
“…Contradictory evidence was reported in patients diagnosed with anxiety neuroses with increased concentrations of circulating catecholamines, who were shown to be more responsive than normal controls to local injections of the cholinomimetic carbachol and phenylephrine [77,78,79]. However, as the intradermal injection of Botox is highly effective at preventing sweating [80], circulating catecholamines on their own are not capable of eliciting the primary sweat response during periods of acute psychological stress [81], suggesting that the humoral factors play little or no role in the activation of eccrine sweat glands. Sex steroid hormone concentrations have been shown to increase in the initial phase of acute psychosocial stress, though there is no evidence to suggest that they are directly responsible for the innervation of eccrine or apocrine sweat glands [82].…”
Section: Humoral Control Of Psychological Sweatingmentioning
confidence: 99%